Hyperlipidemia is secondary to proteinuria and is completely normalized by angiotensin-converting enzyme inhibition in hypertensive fawn-hooded rats

Nephron

Volumn 77, Issue 3, 1997, Pages 346-352

  Verseput, Gaico H ^a,b   Provoost, Abraham P ^a   Van Tol, Arie ^c   Koomans, Hein A ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Apolipoprotein B; Cholesterol; Colloid osmotic pressure; Lisinopril; Triglycerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; TRIACYLGLYCEROL;

AGING; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; HYPERLIPIDEMIA; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 0030659837     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190299     Document Type: Article

References (30)

1. Kreisberg JI, Kamovsky MJ: Focal glomerular sclerosis in the fawn-hooded rat. Am J Pathol 1978;92:637-652.
2. Provoost AP, De Keijzer MH: The fawn-hooded rat: A model for chronic renal failure; in Gretz N, Strauch M (eds): Experimental and Genetic Rat Models of Chronic Renal Failure. Basel, Karger, 1993, pp 100-114.
3. Keane WF: Lipids and the kidney. Kidney Int 1994;46:910-920.
4. Reaven GM, Twersky J, Chang H: Abnormalities of carbohydrate and lipid metabolism in Dahl rats. Hypertension 1991;18:630-635.
5. Mondon CE, Plato PA, Dall'Aglio E, Sztalrvd C, Reaven G: Mechanism of hypertriglyceridemia in Dahl rats. Hypertension 1993:21: 373-379.
6. Hirano T, Ebara T, Furukawa S, Nagano S, Takahashi T: Mechanism of hypertriglyceridemia in Dahl salt-sensitive rats, an animal model of spontaneous nephrotic syndrome. Metabolism 1994;43:248-256.
7. Reaven GM, Chang H: Relationship between blood pressure, plasma insulin and triglyceride concentration, and insulin action in spontaneous hypertension and Wistar-Kvoto rats. Am J Hypertens 1991;4:34-38.
8. Feld LG, Van Liew JB, Galaske RG, Boylan JW: Selectivity of renal injury in the spontaneously hypertensive rat. Kidney Int 1977:12: 332-343.
9. Kamanna VS, Kirschenbaum MA: Association between very-low-density lipoprotein and glomerular injury in obese Zucker rats. Am J Nephrol 1993;13:53-58.
10. Imai Y, Matsumura H, Miyajima H, Oka K: Scrum and tissue lipids and glomerulonephritis in the spontaneously hypercholesterolcmic rat, with a note on the effects of gonadectomy. Atherosclerosis 1977;27:165-178.
11. Joles JA, van Goor H, Braam B, Willekes-Kool-schijn N, Jansen EHJM, van Tol A, Koomans HA: Proteinuria, lipoproteins and renal apoli-poprotcin deposits in uninephrcctomized female analbuminemic rats. Kidney Int 1995:47: 442-453.
12. Simons JL, Provoost AP, Anderson S, Rennke HG, Troy JL, Brenner BM: Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Kidney Int 1994;46:396-404.
13. Verseput GH, Provoost AP, Braam B, Weening JJ, Koomans HA: Glomerular hemodynamic and anti-albuminuric effects of early and late onset of angiotensin converting enzyme inhibition in fawn-hooded rats (abstract). J Am Soc Nephrol 1995;6:1034.
14. Watanabe N, Kamei S, Ohkubo A, Yamanaka M, Ohsawa S, Makino K, Tokuda K: Urinary protein measured with pyrolgallol red molyb-date complex. Clin Chem 1986:32:1551-1554.
15. Dallinga-Thie GM, Groot PHE, van Tol A: Electroimmunoassay of rat apolipoproteins A-I, A-IV and E. A procedure for sample treatment to increase the sensitivity in diluted fractions. J Lipid Res 1985;26:889-892.
16. Van Tol A, Jansen EJHM, Koomans HA, Joles JA: Characterization of hyperlipoproteinemia in Nagase analbuminemic rats: Effects of pravastatin. an HMG-CoA reductase inhibitor, on plasma apolipoproteins. lipoprotein profile and lecithin: cholesterol acyltransferasc activity. J Lipid Res 1991;32:1719-1728.
17. Anderson S, Rennke HG, Zatz R: Glomerular adaptations with normal aging and with longterm converting enzyme inhibition in rats. Am J Physiol 1994;267:F35-F43.
18. Notoya M, Nakamura M, Mizojiri K: Effects of lisinopril on the structure of renal arterioles. Hypertension 1996;27:364-370.
19. O’Donnell MP, Kasiske BL. Keane WF: Risk factors for glomerular injury in rats with genetic hypertension. Am J Hypertens 1989:2:9-13.
20. Sadur CN, Eckel RH: Insulin stimulation of adipose tissue lipoprotein lipase: Use of the euglycemic clamp technique. J Clin Invest 1982;69:1119-1125.
21. Beynen AC, De Bruijne JJ. Kalan MB: Treatment of young rats with cholestyramine or a hypcrcholcsterolemic diet docs not influence the response of serum cholesterol to dietary cholesterol in later life. Atherosclerosis 1985: 58:149-157.
22. Takahashi M, Kusumi K, Shumiya S, Nagase S: Plasma lipid concentrations and enzyme activities in Nagase analbuminemia rats. Exp Anim 1983;32:39-46.
23. Warwick GL, Fox JG, Boulton-Jones JM: The relationship between urinary albumin excretion rate and serum cholesterol in primary glomerular disease. Clin Nephrol 1994;41:135-137.
24. Davies RW, Staprans I, Hutehison FN, Kaysen GA: Portcinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat. J Clin Invest 1990;86:600-605.
25. Van Goor H, van der Horst MLC, Grond J: Prevention of proteinuria by converting enzyme inhibition does not affect mesangial expansion in rats after renal ablation (abstract). Kidney Int 1992,42:795.
26. Dullaart RP, Gansevoort RT, Dikkeschei BD, de Zeeuw D, de Jong PE, van Tol A: Role of elevated lecithinxholesterol acyltransferasc and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients. Kidney Int 1993;44:91-97.
27. Keilani T, Schlucter WA, Levin ML, Battle DC: Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor. Ann Intern Med 1993;118:246-254.
28. O'Donnell MP, Kasiske BL, Katz SA, Schmitz PG, Keane WF: Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats. Hypertension 1992:20:651-658.
29. Hutchison FN, Martin VI, Jones H Jr., Kaysen GA: Differing actions of dietary protein and enalapril on renal function and proteinuria. Am J Physiol 1990;258:F126-F132.
30. Attman P-O, Alaupovic P: Lipid and apolipo-protein profile of uremic dyslipoproteinemia -Relation to renal function and dialysis. Nephron 1991;57:401-410.